Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy

Affiliations

• ¹ Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
• ² GIGA-institute, University of Liège, Liège, Belgium.
• ³ Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
• ⁴ Center for Cancer Biology, VIB, Leuven, Belgium.
• ⁵ Institute for Pathology, University Hospital Cologne, Cologne, Germany.
• ⁶ Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
• ⁷ Max Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
• ⁸ Faculty of Medicine, University of Münster, Münster, Germany.
• ⁹ Cells-in-Motion Cluster of Excellence, University of Münster, Münster, Germany.
• ¹⁰ Laboratory of Medical Chemistry, University of Liège, Liège, Belgium.
• ¹¹ Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands.
• ¹² Metabolomics Core Facility, Center for Cancer Biology, VIB, Leuven, Belgium.
• ¹³ Unit of Animal Genomics, University of Liège, Liège, Belgium.
• ¹⁴ Medical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
• ¹⁵ WELBIO, University of Liège, Liège, Belgium.
• ¹⁶ Laboratory of Cancer Signaling, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.
• ¹⁷ GIGA-institute, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.
• ¹⁸ WELBIO, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.